Skip to main content
Harold Keer, MD, Oncology, Stanford, CA

Harold N. Keer MD PhD

Genitourinary Oncology, Hematologic Oncology


Chief Medical Officer, Taiho Oncology, Inc.

Join to View Full Profile
  • 300 Pasteur DrStanford, CA 94305

  • Phone+1 650-723-4000

Dr. Keer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Oncologist leading R& D efforts at Taiho Oncology, Inc. as Chief Medical Officer

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1994 - 1997
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1990 - 1993
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ...
    Harold N. Keer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Oncology Breakthroughs Could Impact Dentistry
    Oncology Breakthroughs Could Impact DentistryApril 24th, 2025
  • Taiho Oncology Presents Real-World Findings for LONSURF® at the ASCO Gastrointestinal Cancers Symposium
    Taiho Oncology Presents Real-World Findings for LONSURF® at the ASCO Gastrointestinal Cancers SymposiumJanuary 25th, 2025
  • Taiho Oncology Data at ASH Annual Meeting Highlight Progress in Oral Therapies for Patients with Blood Cancers
    Taiho Oncology Data at ASH Annual Meeting Highlight Progress in Oral Therapies for Patients with Blood CancersDecember 9th, 2024
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: